Skip to main content
Clinical Trials/NCT04939376
NCT04939376
Unknown
Not Applicable

Association Between Uterine , Intracavitary , Cervical and Cervical Canal Lesions With in Vitro Fertilization/Intracytoplasmic Sperm Injection(IVF/ICSI) Outcome.

Assiut University0 sites122 target enrollmentJuly 1, 2021
ConditionsIVF

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
IVF
Sponsor
Assiut University
Enrollment
122
Primary Endpoint
Pregnancy rate
Last Updated
4 years ago

Overview

Brief Summary

  1. To study the effect of uterine wall , intracavitary , cervical as well as cervical canal lesion on the outcome of IVF/ICSI cycle.
  2. To establish a score for prediction of IVF/ICSI cycle success .

Detailed Description

IVF is one of the most successful treatment of fertility, (1) however, several IVF cycles fail to achieve pregnancy (2).failure defined as three or more failed attempts of ICSI (3). Implantation failure is a complex in nature, may be due to structural or functional causes (3, 4). that previously undiagnosed, misinterpreted initial diagnoses, or subtle newly added intrauterine abnormalities may be a significant cause of IVF failure (5, 6), studies say that intra-uterine pathologies represent 40-50 % of causes of ICSI failure (7, 8), hysteroscopic removal of endometrial polyps, submucous fibroids, uterine septum, or intrauterine adhesions could increase the pregnancy rate (9). so, Evaluation of the uterine cavity may become a routine investigation before assisted reproductive technology(ART) procedures (10). In this study, we evaluate the relationship between the different uterine and cervical pathologies and decreased live birth rate.

Registry
clinicaltrials.gov
Start Date
July 1, 2021
End Date
April 1, 2024
Last Updated
4 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Khaled Mostafa Ahmed

doctor

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Women between 18 and 38 years old.
  • An indication for IVF/ICSI..
  • Women with BMI between 18.5 : 29.9 .
  • Women with normal antimullerian hormone(AMH), antral follicle count(AFC) (good responders).

Exclusion Criteria

  • Refusal to join the study.
  • Women with age less than 18 and more than 38 .
  • Women with BMI less than 18.5 and more than 30 .
  • Untreated tubal hydrosalpinges.
  • Poor responders as assessed by AFC 4 or less ,AMH O.8 ng/dl (nice 2013).

Outcomes

Primary Outcomes

Pregnancy rate

Time Frame: Baseline

Pregnancy rate with IVF/ICSI with uterine lesions

Similar Trials